Publikationen
| 1. | Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model. Saraswati S, Pandey M, Mathur R, Agrawal SS
Microvasc Res. 2011 Nov;82(3):263-8.
|
| 2. | 3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity. Goel A, Ahmad FJ, Singh RM, Singh GN
J Pharm Pharmacol. 2010 Feb;62(2):273-8.
|
| 3. | BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosis. Tripathi YB
Recent Pat Inflamm Allergy Drug Discov. 2009 Jan;3(1):49-57.
|
| 4. | Thrombin-induced expression of endothelial CX3CL1 potentiates monocyte CCL2 production and transendothelial migration. Popovic M, Laumonnier Y, Burysek L, Syrovets T, Simmet T
J Leukoc Biol. 2008 Jul;84(1):215-23.
|
| 5. | Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice. Cuaz-Pérolin C, Billiet L, Baugé E, Copin C, Scott-Algara D, Genze F, Büchele B, Syrovets T, Simmet T, Rouis M
Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):272-7.
|
| 6. | Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia. Roy S, Khanna S, Krishnaraju AV, Subbaraju GV, Yasmin T, Bagchi D, Sen CK
Antioxid Redox Signal. 2006 Mar-Apr;8(3-4):653-60.
|
| 7. | Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cells. Roy S, Khanna S, Shah H, Rink C, Phillips C, Preuss H, Subbaraju GV, Trimurtulu G, Krishnaraju AV, Bagchi M, Bagchi D, Sen CK
DNA Cell Biol. 2005 Apr;24(4):244-55.
|
| 8. | Anti-inflammatory properties of BHUx, a polyherbal formulation to prevent atherosclerosis. Tripathi YB, Reddy MM, Pandey RS, Subhashini J, Tiwari OP, Singh BK, Reddanna P
Inflammopharmacology. 2004;12(2):131-52.
|